The material highlights career opportunities and lifestyle amenities available in the San Diego region.
Votes cast by attendees at the MetroConnect Grand Prize PitchFest on June 7 will determine which company is awarded the money.
The private company based in Oceanside and Galway, Ireland, provides solutions to resolve severe and chronic wounds worldwide.
San Diego biotech Cidara Therapeutics reported a net loss of $16.7 million in the first quarter, compared to a $13.14 million net loss in the first quarter of last year.
PHARMA: Partnerships and Promising Pipeline Boost Co.
When Stanley Crooke formed Ionis Pharmaceuticals in 1989, he saw the venture as a longshot. He told investors as much.
San Diego-based Escient Pharmaceuticals launched with a $40 million Series A round, which will go toward a pipeline of novel drugs.
San Diego-based Neurana Pharmaceuticals raised $60 million in Series A financing for a relaxant that treats acute, painful muscle spasms.
Solana Beach-based Luna DNA raised $2 million in a new round of funding, led by Illumina Ventures and Arch Venture Partners, it was announced May 8.
The new hires have assumed key positions in two of Maravai LifeSciences operating businesses: TriLink BioTechnologies and Cygnus Technologies.
CalciMedica focuses on calcium release-activated calcium (CRAC) channel drug discovery and development for the treatment of acute and chronic inflammatory diseases.
Seqster's platform standardizes data from electronic medical records (EMRs), wearables, such as FitBit, and genomics reports, such as those produced by companies such as 23andMe.
The Scripps Translational Science Institute (STSI) was awarded $34 million in renewed funding to advance genomic and digital technologies in clinical care.
AMN Healthcare reported $522 million in quarter one revenue, up 6 percent year over year, fueled by higher-than-expected staffing needs.
TRADE: S.D. Cos. Able to Avoid Some of the Complexities
San Diego biotechs are inking deals with Chinese firms to tap into China’s ever-growing demand for groundbreaking drugs.
San Diego-based Dexcom reported a 30 percent year-over-year revenue increase in quarter one results due a sharp increase in international sales.